Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Walling DP"" wg kryterium: Autor


Wyświetlanie 1-17 z 17
Tytuł:
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
Autorzy:
Walling DP
Hassman HA
Anta L
Ochoa L
Ayani I
Martínez J
Gutierro I
Pokaż więcej
Temat:
bioequivalence
comparative bioavailability
long-acting injectables
lais
pharmacokinetic
risperidone
schizophrenia
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 15, Pp 4371-4382 (2021)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/the-steady-state-comparative-bioavailability-of-intramuscular-risperid-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/a256d4300d484f2c90cfa6b6c8041253  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]
Autorzy:
Walling DP
Hassman HA
Anta L
Ochoa L
Ayani I
Martínez J
Gutierro I
Pokaż więcej
Temat:
bioequivalence
comparative bioavailability
long-acting injectables
lais
pharmacokinetic
risperidone
schizophrenia
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 16, Pp 1791-1792 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/corrigendum-the-steady-state-comparative-bioavailability-of-intramuscu-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/72234dfaaa7a41919e747cfd6aa4e887  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
Autorzy:
Wang W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. .; Research and Development Center, Luye Pharma, Yantai, Shandong, China. .; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. .
Wang X; ClinPharm Solutions LLC, Chester, NJ, USA.
Dong Y; Global Clinical Development, Luye Pharma (US), Ltd., Princeton, NJ, USA.
Walling DP; CenExel-CNS, Garden Grove, CA, USA.
Liu P; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China.
Liu W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China.
Shi Y; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China.
Sun K; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. .; Research and Development Center, Luye Pharma, Yantai, Shandong, China. .; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. .
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr; Vol. 13 (2), pp. 355-372. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.
Autorzy:
Nasrallah HA; University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3200, Cincinnati, OH, 45219, USA. .
Weiden PJ; Alkermes, Inc., Waltham, MA, USA.
Walling DP; CNS Network, LLC, Garden Grove, CA, USA.
Du Y; Alkermes, Inc., Waltham, MA, USA.
Yao B; Alkermes, Inc., Waltham, MA, USA.
Yagoda S; Alkermes, Inc., Waltham, MA, USA.
Claxton A; Alkermes, Inc., Waltham, MA, USA.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2021 Oct 08; Vol. 21 (1), pp. 492. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antipsychotic Agents*/therapeutic use
Schizophrenia*/drug therapy
Adult ; Aripiprazole/therapeutic use ; Humans ; Paliperidone Palmitate/therapeutic use ; Patient Reported Outcome Measures ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
Autorzy:
Adams DH
Kinon BJ
Baygani S
Millen BA
Velona I
Kollack-Walker S
Walling DP
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2013 May 22; Vol. 13, pp. 143. Date of Electronic Publication: 2013 May 22.
Typ publikacji:
Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Amino Acids/*therapeutic use
Antipsychotic Agents/*therapeutic use
Schizophrenia/*drug therapy
Adolescent ; Adult ; Aged ; Amino Acids/adverse effects ; Antipsychotic Agents/adverse effects ; Aripiprazole ; Benzodiazepines/adverse effects ; Benzodiazepines/therapeutic use ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Male ; Middle Aged ; Olanzapine ; Piperazines/adverse effects ; Piperazines/therapeutic use ; Quinolones/adverse effects ; Quinolones/therapeutic use ; Risperidone/adverse effects ; Risperidone/therapeutic use ; Standard of Care ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.
Autorzy:
Targum SD; Clintara LLC, 505 Tremont Street, Boston, MA, 02116, USA. .
Houser C
Northcutt J
Little JA
Cutler AJ
Walling DP
Pokaż więcej
Źródło:
Annals of general psychiatry [Ann Gen Psychiatry] 2013 Jan 31; Vol. 12 (1), pp. 2. Date of Electronic Publication: 2013 Jan 31.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-17 z 17

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies